In response to Rising: I agree with you that with the currently heightened global uncertainty and investors being more risk averse in their portfolios, we will likely see IMU drift lower short term due to its speculative nature. But no news soon? The Vaxinia and onCARlytics trial updates are both on track to be released at the end of this month / early next month. While Imugene have a reputation of pushing back trials and not reaching their own set deadlines (frustrating for all), the fact that they have maintained the dot points in their Key Catalysts across two subsequent presentations would have me believe that these are well and truly on track. It would be bizzare to leave in dot points in a presentation on the 27th of Feb that alludes to data being released a month later, and then not follow through! Hoping I am am correct on this, and the data represents a "key catalyst" that can reverse the current down trend, but I guess we'll just have to wait and see! Good luck to all and DYOR.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)